Analysis of buprenorphine distribution patterns among pharmacies and hospitals in the USA from 2019 to 2023
Background Opioid use disorder (OUD) is a debilitating condition characterised by the overuse of opioid medications and the development of physical and/or psychological dependence. Consequences of this condition include chronic impairment, distress and later life-altering health conditions such as o...
Saved in:
| Main Authors: | Brian J Piper, Andrew George, Maria Gikoska, Anna K Florio |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/7/e094454.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Community pharmacy attitudes and behaviors following a buprenorphine best practices dissemination
by: Winter Roth, PharmD, BCPP, et al.
Published: (2025-04-01) -
Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
by: Minna M. Kanervo, et al.
Published: (2023-03-01) -
Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder
by: Laura B. Monico, et al.
Published: (2025-02-01) -
Pharmacy students’ opinion on mandatory summer internships carried out in community and hospital pharmacies
by: Lucyna Bułaś, et al.
Published: (2025-01-01) -
Advancing emergency department–initiated buprenorphine
by: Kristen Huntley, et al.
Published: (2021-06-01)